Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04560712 · ClinicalTrials.gov registry record · NA
Acupuncture for the Management of Postoperative Pain in Patients With Pancreatic or Colorectal Cancer Undergoing Surgery
A NA study of Resectable Colorectal Carcinoma and Resectable Pancreatic Carcinoma, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT04560712: Active NA study of Resectable Colorectal Carcinoma and Resectable Pancreatic Carcinoma, sponsored by M.D. Anderson Cancer Center.
NCT04560712 is a NA study of Resectable Colorectal Carcinoma and Resectable Pancreatic Carcinoma that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 70 participants, below the 102-participant average among 3 other Resectable Colorectal Carcinoma trials with a reported enrollment target (31% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04560712, a NA study of Resectable Colorectal Carcinoma and Resectable Pancreatic Carcinoma, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial investigates how well acupuncture works for the management of pain after surgery in patients having open colorectal or pancreatic surgery. Acupuncture may help to reduce postoperative symptoms including pain. This study may help researchers learn if acupuncture reduces after-surgery side effects and improves recovery.
Primary Outcome
Acupuncturist will document in the medical record all the treatments participants are completing and also document if missing any treatments.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- OTHER Best Practice
- PROCEDURE Acupuncture Therapy
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2020-08-12 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
What the registry record for NCT04560712 still lists
NCT04560712 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 102-participant average among 3 other Resectable Colorectal Carcinoma trials with a reported enrollment target (31% lower).
The record links to 3 conditions, with Resectable Colorectal Carcinoma appearing as the primary indexed condition, and to 3 interventions - of which Questionnaire Administration is the first listed.
NCT04560712 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04560712 about?
NCT04560712 is a clinical study titled "Acupuncture for the Management of Postoperative Pain in Patients With Pancreatic or Colorectal Cancer Undergoing Surgery". This trial investigates how well acupuncture works for the management of pain after surgery in patients having open colorectal or pancreatic surgery. Acupuncture may help to reduce postoperative symptoms including pain. This study may help researchers learn if acupuncture reduces after-surgery side ...
What is the current status of trial NCT04560712?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2020-08-12. Estimated completion is 2027-12-31.
What conditions does trial NCT04560712 study?
This clinical trial studies the following conditions: Resectable Colorectal Carcinoma, Resectable Pancreatic Carcinoma, Resectable Digestive System Carcinoma.
What interventions are being tested in trial NCT04560712?
The interventions under investigation include: Questionnaire Administration (OTHER), Best Practice (OTHER), Acupuncture Therapy (PROCEDURE).
Who is sponsoring clinical trial NCT04560712?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04560712 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Resectable Colorectal Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
An Investigational Scan (Intravoxel Incoherent Motion Diffusion Weighted Imaging) for the Evaluation of Colorectal Cancer Liver Metastases Treatment Response
RECRUITING · NA
-
Intravital Microscopy in Human Solid Tumors
RECRUITING · NA
-
Minimal Residual Disease Testing for the Early Detection of Cancer Recurrence in Resectable Stage II-IV Colorectal Cancer Patients
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI